BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3115214)

  • 1. [Pathogenesis of cerebral vasospasm: with special references to the response of fresh human cerebral arteries to red blood cell hemolysate and the changes in the responses of cerebral arteries to vasoconstrictor substances after subarachnoid hemorrhage].
    Handa Y
    Nihon Geka Hokan; 1987 Mar; 56(2):124-37. PubMed ID: 3115214
    [No Abstract]   [Full Text] [Related]  

  • 2. Augmentation of both hemolysate-induced contraction and activation of protein kinase C by submaximum activation in canine cerebral arteries in vitro.
    Kawamata T; Peterson JW; Bun T; Zervas NT
    J Neurosurg; 1997 Dec; 87(6):908-15. PubMed ID: 9384403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrovascular sensitivity to vasoconstricting agents induced by subarachnoid hemorrhage and vasospasm in dogs.
    Toda N; Ozaki T; Ohta T
    J Neurosurg; 1977 Mar; 46(3):296-303. PubMed ID: 839255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual variations in response of human cerebral arterioles to vasoactive substances, human plasma, and CSF from patients with aneurysmal SAH.
    Brandt L; Ljunggren B; Andersson KE; Hindfelt B
    J Neurosurg; 1981 Sep; 55(3):431-7. PubMed ID: 7264734
    [No Abstract]   [Full Text] [Related]  

  • 5. Endothelin: an endothelium-derived vasoactive peptide and its possible role in the pathogenesis of cerebral vasospasm.
    Alafaci C; Salpietro FM; Iacopino DG; Edvinsson L; Tomasello F
    Ital J Neurol Sci; 1991 Jun; 12(3 Suppl 11):55-8. PubMed ID: 1757224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses of isolated cerebral arteries to vasoactive agents.
    White RP
    Neurosurg Clin N Am; 1990 Apr; 1(2):401-15. PubMed ID: 2136151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic changes in cerebral arteries after subarachnoid hemorrhage.
    Mayberg MR; Okada T; Bark DH
    Neurosurg Clin N Am; 1990 Apr; 1(2):417-32. PubMed ID: 2136152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonpeptide endothelin antagonist. Cerebrovascular characterization and effects on delayed cerebral vasospasm.
    Willette RN; Zhang H; Mitchell MP; Sauermelch CF; Ohlstein EH; Sulpizio AC
    Stroke; 1994 Dec; 25(12):2450-5; discussion 2456. PubMed ID: 7974589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in Mg++ concentration of CSF after subarachnoid hemorrhage and Mg++--effects on the contractions of bovine cerebral artery].
    Miura K
    No Shinkei Geka; 1988 Oct; 16(11):1251-9. PubMed ID: 3211273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subarachnoid hemorrhage induces enhanced expression of thromboxane A2 receptors in rat cerebral arteries.
    Ansar S; Larsen C; Maddahi A; Edvinsson L
    Brain Res; 2010 Feb; 1316():163-72. PubMed ID: 20026315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y: vasoconstrictor effects and possible role in cerebral vasospasm after experimental subarachnoid hemorrhage.
    Abel PW; Han C; Noe BD; McDonald JK
    Brain Res; 1988 Nov; 463(2):250-8. PubMed ID: 3196916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cerebral vasospasm in subarachnoid hemorrhage--with reference to its mechanism (author's transl)].
    Ishii S; Nonaka T
    No To Shinkei; 1977 Aug; 29(8):829-40. PubMed ID: 332203
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of endothelium in cerebral vasospasm.
    Sasaki T; Kassell NF
    Neurosurg Clin N Am; 1990 Apr; 1(2):451-63. PubMed ID: 2136154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenesis of cerebral vasospasm].
    Adler H
    Neurochirurgia (Stuttg); 1974 Nov; 17(6):202-8. PubMed ID: 4156392
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cerebral vasospasm following subarachnoid hemorrhage as studied from the mechanism of physiological smooth muscle contraction].
    Sakaki S; Ohta S
    No Shinkei Geka; 1996 Jan; 24(1):19-28. PubMed ID: 8559260
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lipid peroxidation and cerebral vasospasm (author's transl)].
    Asano T; Sasaki T; Sano K
    No To Shinkei; 1981 Jan; 33(1):33-46. PubMed ID: 7470332
    [No Abstract]   [Full Text] [Related]  

  • 17. Erythrocyte extracts enhance neurogenic vasoconstriction of dog cerebral arteries in vitro.
    Lee TJ; McIlhany MP; Sarwinski S
    J Cereb Blood Flow Metab; 1984 Sep; 4(3):474-6. PubMed ID: 6470062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of plasmin, thrombin, and antithrombin III as etiological factors in delayed cerebral vasospasm.
    White RP; Robertson JT
    Neurosurgery; 1985 Jan; 16(1):27-35. PubMed ID: 2579347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
    Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study of cerebral vasospasm -biochemical analysis of vasoconstrictor in the red blood cell hemolysate and the mechanism of action (author's transl)].
    Okamoto S
    Nihon Geka Hokan; 1982 Jan; 51(1):93-103. PubMed ID: 7092469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.